🦠 Vaccines: A Key Weapon Against Antimicrobial Resistance (AMR) A recent WHO report underscores the powerful role of vaccines in the fight against AMR, estimating that better use of vaccines
Despite the challenges posed by the ongoing conflict, Ukraine’s healthcare sector demonstrates remarkable resilience and adaptability. The country’s efforts to maintain and enhance its healthcare and research infrastructure are also
I enjoy working as CRO and Trial Acceleration company in the highly challenging setting of Intensive Care – as agile, committed smaller companies we can show we make a difference
Client 4SC AG: The Marketing Authorisation Application for resminostat has been accepted by the EMA as sufficient for examination. “Germany, 1 March 2024 – 4SC AG a biotech company improving
Are any of your clinical trials held back by slow recruitment? The start for a successful clinical study is to efficiently recruit and retain the study population. But participant enrolment
Up to 70% of premature cancer deaths among women are preventable, WHO-led analysis shows. Key takeaways: Most premature cancer deaths among women are preventable: nearly seven in 10 premature cancer-related
There are roughly 2,500 public medical facilities in Ukraine that have previously run international clinical trials, and it was an average of 500 clinical trials were ongoing in Ukraine each year, before 24 Feb 2022.
When I moved to Estonia, I understood that the Baltic Sea is one of the most polluted bodies of water on Earth. Nutrient runoff causes algal blooms, depleting oxygen and making water
Sepsis remains one of the most common and least-recognized illnesses in both the developed and developing world. The Global Burden of Disease Sepsis Report published in January 2020 estimated that
Its accounting for about 8 million deaths each year. Mortality for severe sepsis is between 15% and 30% in high-income countries with high standard of care and > 50% in
The Estonian Biobank has established a population-based biobank of Estonia with a current cohort size of more than 200,000 individuals (genotyped with genome-wide arrays), reflecting the age, sex and geographical
